120 related articles for article (PubMed ID: 37365054)
1. Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion.
Barletta F; Tappero S; Morra S; Incesu RB; Cano Garcia C; Piccinelli ML; Scheipner L; Baudo A; Tian Z; Gandaglia G; Stabile A; Mazzone E; Terrone C; Longo N; Tilki D; Chun FKH; de Cobelli O; Ahyai S; Carmignani L; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2023 Dec; 21(6):e461-e466.e1. PubMed ID: 37365054
[TBL] [Abstract][Full Text] [Related]
2. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
3. Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients.
Barletta F; Tappero S; Morra S; Incesu RB; Cano Garcia C; Piccinelli ML; Scheipner L; Tian Z; Gandaglia G; Stabile A; Mazzone E; Terrone C; Longo N; Tilki D; Chun FKH; de Cobelli O; Ahyai S; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
J Surg Oncol; 2024 Jun; 129(7):1305-1310. PubMed ID: 38470523
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
5. A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.
Abdollah F; Schmitges J; Sun M; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Prostate; 2011 Oct; 71(14):1587-94. PubMed ID: 21480307
[TBL] [Abstract][Full Text] [Related]
6. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
[TBL] [Abstract][Full Text] [Related]
7. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Lymph Node Metastases Burden at Radical Prostatectomy.
Preisser F; Marchioni M; Nazzani S; Bandini M; Tian Z; Pompe RS; Montorsi F; Saad F; Abdollah F; Steuber T; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):399-406. PubMed ID: 29306731
[TBL] [Abstract][Full Text] [Related]
9. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.
Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Montorsi F; Saad F; Briganti A; Steuber T; Budäus L; Huland H; Graefen M; Tilki D; Karakiewicz PI
Urol Oncol; 2018 Aug; 36(8):365.e1-365.e7. PubMed ID: 29887241
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era.
Scheipner L; Barletta F; Cano Garcia C; Incesu RB; Morra S; Baudo A; Assad A; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Tilki D; Longo N; Carmignani L; Pichler M; Ahyai S; Karakiewicz PI
Ann Surg Oncol; 2023 Dec; 30(13):8780-8785. PubMed ID: 37815682
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.
Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S
Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomy.
Stolzenbach LF; Knipper S; Mandel P; Ascalone L; Deuker M; Tian Z; Heinzer H; Tilki D; Maurer T; Graefen M; Karakiewicz PI; Steuber T
Urol Oncol; 2021 Apr; 39(4):234.e1-234.e7. PubMed ID: 33097398
[TBL] [Abstract][Full Text] [Related]
13. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Fossati N; Gandaglia G; Gallina A; Abdollah F; Shariat SF; Montorsi F; Saad F; Tilki D; Briganti A; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):381-388. PubMed ID: 29366856
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
Tafuri A; Rizzetto R; Amigoni N; Sebben M; Shakir A; Gozzo A; Odorizzi K; Gallina S; Bianchi A; Ornaghi P; Brunelli M; Migliorini F; Cerruto MA; Artibani W; Siracusano S; Antonelli A; Porcaro AB
Urol Int; 2021; 105(5-6):362-369. PubMed ID: 33059351
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.
Suardi N; Gandaglia G; Gallina A; Di Trapani E; Scattoni V; Vizziello D; Cucchiara V; Bertini R; Colombo R; Picchio M; Giovacchini G; Montorsi F; Briganti A
Eur Urol; 2015 Feb; 67(2):299-309. PubMed ID: 24571959
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymph node count in surgically treated patients with T
Assad A; Barletta F; Incesu RB; Scheipner L; Morra S; Baudo A; Garcia CC; Tian Z; Ahyai S; Longo N; Chun FKH; Shariat SF; Tilki D; Briganti A; Saad F; Karakiewicz PI
Urol Oncol; 2024 Aug; 42(8):248.e1-248.e9. PubMed ID: 38653591
[TBL] [Abstract][Full Text] [Related]
18. The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients.
Wenzel M; Würnschimmel C; Nocera L; Collà Ruvolo C; Tian Z; Shariat SF; Saad F; Briganti A; Graefen M; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
Prostate; 2021 May; 81(6):339-346. PubMed ID: 33666271
[TBL] [Abstract][Full Text] [Related]
19. Oncologic outcomes of organ-confined Gleason grade group 4-5 prostate cancer after radical prostatectomy.
Preisser F; Wang N; Abrams-Pompe RS; Chun FK; Graefen M; Huland H; Tilki D
Urol Oncol; 2022 Apr; 40(4):161.e9-161.e14. PubMed ID: 34973856
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy.
Preisser F; Incesu RB; Rajwa P; Chlosta M; Ahmed M; Abreu AL; Cacciamani G; Ribeiro L; Kretschmer A; Westhofen T; Smith JA; Graefen M; Calleris G; Raskin Y; Gontero P; Joniau S; Sanchez-Salas R; Shariat SF; Gill I; Karnes RJ; Cathcart P; Van Der Poel H; Marra G; Tilki D
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
